Keywords: Abcam, Epitomics Interantional, M&A, Financial results, Chinese antibody operation, Rabbit MAbs

Abcam to buy Epitomics for $170 million

Article | 06 March 2012

Print This

In a second acquisition within six months, UK-based protein research tools supplier Abcam (AIM: ABC) has entered into a definitive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in